4th Annual Biomanufacturing Asia

2
Produced by: Associations: International Marketing Partner: www.biomanufacturing-asia.com Increasing Production, Enhancing Quality & Optimizing Operations Part of PRODUCTION BIOPHARMA DEVELOPMENT & WEEK 20 — 23 May 2014 Grand Hyatt Shanghai, China IBC LIFE SCIENCES PLUS: WUXI APPTEC SANOFI NOVARTIS TAKEDA PHARMACEUTICAL BAXTER & many more! BIO BIO 4 TH ANNUAL Jingrong Li Executive Director, Biologics, SIMCERE PHARMACEUTICALS, CHINA Key Conference Themes: Regulations, GMP & Standards Successful Partnerships, Investment & Financing Effective Planning, Facility Design & Development Improving Operations & Supply Chain Management Cost Effective Single-Use Systems & Technology Transfer Steven Lee Global Head of Biologics Tech Operations & Managing Director, DR. REDDY’S LABORATORIES, SINGAPORE THE 2014 NEW EXPERT FACULTY INCLUDES: Ting Xu Founder & CEO, ALPHAMAB, CHINA Racho Jordanov President & CEO, JHL BIOTECH, TAIWAN PRE-CONFERENCE WORKSHOP: 20 MAY 2014 Biomanufacturing Technologies & Facility Design POST-CONFERENCE WORKSHOP: 23 MAY 2014 Meeting International Quality & Regulatory Requirements in Biomanufacturing Media Partners: Jeremy Caudill Global VP Business Development, SAMSUNG BIOLOGICS, KOREA Darren Ji Global Head, Asia Emerging Markets Partnering, F. HOFFMANN-LA ROCHE, CHINA Life Sciences

description

The 4th Annual Biomanufacturing Conference is taking place on the 20 - 23 May 2014 at Grand Hyatt, Shanghai. A must go event for you to get the latest updates from the industry, to learn more of the latest developments and best practices in increasing production, enhancing quality and optimizing operations in the biomanufacturing industry. Key Conference Topics GMP & Standards Successful Partnerships, Investment & Financing Effective Planning, Facility Design & Development Improving Operations & Supply Chain Management Cost Effective Single-Use Systems & Technology Transfer

Transcript of 4th Annual Biomanufacturing Asia

Page 1: 4th Annual Biomanufacturing Asia

Produced by: Associations:

International MarketingPartner:

www.biomanufacturing-asia.com

Increasing Production, Enhancing Quality & Optimizing Operations

Part of

PRODUCTION

BIOPHARMADEVELOPMENT &

WEEK

20 — 23 May 2014Grand Hyatt Shanghai, China

IBC LIFESCIENCES

PLUS:

• WUXI APPTEC • SANOFI • NOVARTIS

• TAKEDA PHARMACEUTICAL • BAXTER

& many more!

BIOBIO4TH ANNUAL

Jingrong Li

Executive Director, Biologics,SIMCERE PHARMACEUTICALS, CHINA

Key Conference Themes:• Regulations, GMP & Standards• Successful Partnerships, Investment

& Financing• Effective Planning, Facility Design &

Development• Improving Operations & Supply Chain

Management• Cost Effective Single-Use Systems &

Technology TransferSteven Lee

Global Head of Biologics Tech Operations &Managing Director,DR. REDDY’S LABORATORIES, SINGAPORE

THE 2014 NEW EXPERT FACULTY INCLUDES:

Ting Xu

Founder & CEO,ALPHAMAB, CHINA Racho Jordanov

President & CEO,JHL BIOTECH, TAIWAN

PRE-CONFERENCE WORKSHOP: 20 MAY 2014Biomanufacturing Technologies & Facility Design

POST-CONFERENCE WORKSHOP: 23 MAY 2014Meeting International Quality & Regulatory

Requirements in Biomanufacturing

Media Partners:

Jeremy Caudill

Global VP Business Development,SAMSUNG BIOLOGICS, KOREA

Darren Ji

Global Head, Asia Emerging Markets Partnering,F. HOFFMANN-LA ROCHE, CHINA

LifeSciences

Page 2: 4th Annual Biomanufacturing Asia

REGISTER TODAY! +65 6508 2401 / +86 21 2326 3680 [email protected] www.biomanufacturing-asia.com

About the BDP WeekThe Biopharma Development & Production Week isthe leading industry platform for pharma, biotech,CMOs, CROs, research institutes, investors and industrystakeholders to meet, network and discuss currentindustry trends, establish business partnershipsand be updated on investment opportunities inChina and surrounding Asia.

Visit www.biopharmaproduction.com for moreinformation.

Co-Located with:

30+ Top Level SpeakersNew Pre & Post Interactive Workshops4 Interactive Panel DiscussionsHot Topic Round Table DiscussionsMeet the Experts Via Specially Hosted VIP Lunch TablesSpeed Networking SessionsMorning Ice Breaker & Get to Know your PeersConference Cocktail

Acceleron Pharma • AlphaMab • Amgen • Autekbio • Bayer HealthCare • Berna Biotech Korea • Biopharm Services • BioPharmaNeer Alliance • BioprocessingTechnology Institute • Boehringer Ingelheim • Bristol-Myers Squibb • Celltrion Healthcare • Chugai Pharmaceutical • CMC Biologics • CMC Biologics •Compliance Concepts International • Daewoong Pharmaceutical • DMS Biotechnology • Dow Corning • ExcellGene • Genor Biopharma • Genzyme/Sanofi •Indian Immunologicals • Innobiologics • Innovent Biologics • Mass Biologics • Novasep • Pfizer Biotherapeutics • Sartorius Stedim Biotech • Saint Gobain •SFDA Training Center • Shanghai Henlius Biotech • Swiss Federal Institute of Technology • Wuxi Apptec • Yooyoung Pharmaceutical & many more

20 — 23 May 2014Grand Hyatt Shanghai, China

Part ofPRODUCTION

BIOPHARMADEVELOPMENT &

WEEK

Asian countries such as India, Singapore, South Korea& China are fast becoming biomanufacturing hubs.Biologics manufacturing is a huge investment & canamount to US10 million or more to construct, equip, &launch a successful certified GMP plant facility(Biospectrum Asia, 2013). With the intensifying growth& demand of biologics production, IBC’s 4th Annual

Biomanufacturing Conference provides a timelyplatform to explore the opportunities & challengesfaced in this sector including:

The investment opportunities for entering thebiomanufacturing market in China & the surroundingAsian region

Bridging the quality differences of China GMPStandards vs. Europe & the US

What is the growth potential & opportunity fordisposable technologies in biomanufacturing inChina?

Identifying the critical factors in choosing the rightoutsourcing partner

Developing a robust commercial process fortechnology transfer

Examining the impact of the US H.R. 3204 Drug Quality& Security Act in the biomanufacturing industry

For sponsorship opportunities, contact Yvonne Leong atTel: +65 6508 2489

Email: [email protected]

BY INDUSTRY■ Biopharmaceutical / Pharmaceutical /

Biotechnology 45%

■ Technology and Solution Service Providers 20%

■ CMO 15%

■ Research Institutes 10%

■ Government 10%

www.biosimilarasia.com

www.celllineasia.com

LIMITED SPONSORSHIP & EXHIBITION OPPORTUNITIES AVAILABLEDo you provide innovative technology to support the biomanufacturing Industry in Asia?

• Showcase the latest technology• Meet & network with senior decision makers in Asia• Position your brand as the market leader to stand out amidst

competition• Generate new business contacts & strengthen existing accounts

Who Should Attend

SNAPSHOT OF PAST ATTENDING COMPANIES INCLUDE:

Abundant Networking Opportunities &Interactive Formats!

An International EventChina, Taiwan, Hong Kong 55%

Europe 10%

USA 5%Australia 5%Southeast Asia 10%

Japan,Korea 10%

India 5%